Huntington's Disease Trial, Recruiting NCT06414967 Sponsor: Poitiers University Hospital Condition: Huntington's Disease
Back to Huntingtons Disease

Huntington's Disease Trial, Recruiting

NCT06414967
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with Huntington's disease confirmed by a genetic test showing at least 35 CAG repeats in the HTT gene
  • Your Huntington's disease symptoms are at an early/mild stage, based on a specific rating scale score (UHDRS score of 5 or less, with a confidence score of 4)
  • You do not have significant memory or thinking problems, as shown by a standard cognitive test score of 24 or above (MoCA test)
  • Any medications you are taking have been stable for at least 28 days before joining and will remain stable throughout the study
  • You are able to make your own decisions and are not under legal guardianship
  • You are covered by a health insurance system, as required by French law
  • You are willing and able to provide written consent to take part in the study

Who may not be able to join:

  • You are unable to freely and fully agree to take part in the study on your own
  • You have a significant hearing problem
  • You are already taking part in another clinical study at the time of enrolment
  • You are currently in a protected legal category, including people detained by court or administrative order, adults under legal protection measures, or people in a life-threatening emergency situation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 05 49 44 33 89

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Poitiers University Hospital
Registry
ClinicalTrials.gov
Start date
15 October 2024
Est. completion
1 July 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Describe evolution of irritability in patients with Huntington's disease after 3 months of music therapy combined with conventional management

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov